Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Condom shelf-life testing on first three lots, in lieu of "random" testing, supported by HIMA.

This article was originally published in The Tan Sheet

Executive Summary

LATEX CONDOM SHELF-LIFE TESTING ON INITIAL THREE LOTS should be adequate for FDA in lieu of testing on three "discrete and random lots" as proposed by the agency, the Health Industry Manufacturers Association said in Aug. 22 comments on FDA's May 24 proposed regs for condom labeling. The proposal would allow latex condom expiration dating of up to five years based on short-term accelerated aging studies and follow-up real-time testing ("The Tan Sheet" May 27, In Brief).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS085939

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel